Skip to main content
. 2016 Feb 9;7:18. doi: 10.3389/fphar.2016.00018

Table 1.

Pharmaceutical expenditure indicators according to WHO issued HFA-DBdata for free-market economies in the European Region prior to 1989 (5 out of 25 countries lacking some relevant data from the official records).

First available PE* as % of THE** Last available PE as % of THE Total change PE as % of THE Time span (years) Annual increment First available public PE as % of TPE*** Last available Public PE as % of TPE Total change public PE as % of TPE Time span (years) Annual increment First available PE as PPP$ per capita Last available PE as PPP$ per capita Total change PE as PPP$ per capita Time span (years) Annual increment
Andorra N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Austria 9.61990 11.72011 +2.1 21 0.10 55.11990 67.62011 +12.5 21 0.60 $156.51990 $533.12011 +$376.6 21 $17.93
Belgium 28.11970 15.52011 −12.6 41 −0.31 58.51970 64.32011 +5.8 41 0.14 $41.91970 $630.92011 +$589.0 41 $14.37
Cyprus N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Denmark N/A 6.82011 N/A N/A N/A 49.91980 49.22011 −0.7 31 −0.02 $53.81980 $300.42011 +$246.6 31 $7.95
Finland 12.61970 13.22011 +0.6 41 0.01 33.71970 55.92011 +22.2 41 0.54 $22.81970 $446.22011 +$423.4 41 $10.33
France 23.81970 15.62011 −8.2 41 −0.20 67.31970 682011 +0.7 41 0.02 $46.11970 $641.12011 +$595.0 41 $14.51
Germany 16.21970 14.12011 −2.1 41 −0.05 63.41970 75.62011 +12.2 41 0.30 $43.31970 $632.62011 +$589.3 41 $14.37
Greece 25.51970 28.52011 +3.0 41 0.07 601970 73.72011 +13.7 41 0.33 $40.81970 $673.42011 +$632.6 41 $15.43
Iceland 17.11970 15.42011 −1.7 41 −0.04 43.21970 42.12011 −1.1 41 −0.03 $29.91970 $508.32011 +$478.4 41 $11.67
Ireland 13.71975 17.52011 +3.8 36 0.11 43.41975 782011 +34.6 36 0.96 $37.31975 $647.72011 +$610.4 36 $19.96
Israel 15.51995 14.72011 −0.8 16 −0.05 39.32006 43.72010 +4.4 4 1.10 N/A N/A N/A N/A N/A
Italy 21.81988 15.72012 −6.1 24 −0.25 61.51988 45.52012 −16.0 24 −0.67 $247.21988 $482.22012 +$235.0 24 $9.79
Luxembourg 19.71970 9.12008 −10.6 38 −0.28 83.51970 842008 +0.5 38 0.01 $229.11995 $4062008 +$176.9 13 $13.61
Malta 23.692001 27.982012 +4.29 11 0.39 43.612001 41.22012 −2.41 11 −0.22 N/A N/A N/A N/A N/A
Monaco N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Netherlands 10.31972 9.42011 −0.9 39 −0.02 60.11972 78.42011 +18.3 39 0.47 $32.31972 $479.32011 +$447.0 39 $11.46
Norway 7.81970 6.62012 −1.2 42 −0.03 35.81970 54.52012 +18.7 42 0.45 $11.21970 $390.42012 +$379.2 42 $9.03
Portugal 13.41970 17.92011 +4.5 41 0.11 68.71970 55.12011 −13.6 41 −0.33 $6.31970 $4692011 +$462.7 41 $11.29
San Marino N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Spain 211980 17.42011 −3.6 31 −0.12 641980 712011 +7.0 31 0.23 $761980 $535.82011 +$459.8 31 $14.83
Sweden 6.61970 12.12011 +5.5 41 0.13 62.91970 58.32011 −4.6 41 −0.11 $20.51970 $4742011 +$453.5 41 $11.06
Switzerland 11.31985 9.42011 −1.9 26 −0.07 53.31995 68.92011 +15.6 16 0.98 $164.91985 $530.72011 +$365.8 26 $14.07
Turkey 10.71981 26.62000 +15.9 19 0.84 1001981 60.22000 −39.80 19 −2.09 $9.11981 $120.72000 +$111.6 19 $5.87
United Kingdom 14.71970 11.42008 −3.3 38 −0.09 59.41970 84.72008 +25.3 38 0.67 $23.41970 $374.62008 +$351.2 38 $9.24
MEAN 16.2 15.1 −0.7 33.5 0.01 57.5 62.9 5.4 32.3 0.16 $68.0 $488.2 $420.2 34,1 $12.30
ST DEV 6.2 6.2 6.3 10.1 0.25 15.6 13.8 16.3 11.7 0.68 $74.0 $136.0 $150.5 9,2 $3.18
MIN 6.6 6.6 −12.6 11.0 −0.31 33.7 41.2 −39.8 4.0 −2.09 $6.3 $120.7 $111.6 13 $5.87
MAX 28.1 28.5 15.9 42.0 0.84 100.0 84.7 34.6 42.0 1.10 $247.2 $673.4 $632.6 42 $17.93
MEDIAN 15.1 14.7 −1.1 38.5 −0.04 59.4 64.3 5.8 38.0 0.23 $40.8 $482.2 $447.0 39 $11.67
*

PE, Pharmaceutical expenditure.

**

THE, Total health expenditure.

***

TPE, Total pharmaceutical expenditure.